Dr. Caesar Hernandez, Nanomedicine ,Best Researcher Award

Dr. Caesar Hernandez, Nanomedicine ,Best Researcher Award

Dr. Caesar Hernandez at The University of Alabama at Birmingham,United States Korea

Author Profile

šŸŽ“ Education

  • 2018: PhD in Medical Sciences, Concentration in Neuroscience, University of Florida
    • Thesis: “Circuit and Molecular Mechanisms of Altered Decision Making in Aging” (Advisors: Dr. Jennifer Lynn Bizon and Dr. Barry Setlow)
  • 2014: MS in Biological Sciences, Florida Atlantic University
    • Thesis: “Methionine Reductase Sulfoxide (Msr) Deficiency Leads to a Reduction of Dopamine Levels in Drosophila” (Advisors: Dr. David Binninger and Dr. Herbert Weissbach)
  • 2011: BS in Biological Sciences with a Minor in Biotechnology, Magna Cum Laude, Florida Atlantic University
  • 2009: AA in Biology, Palm Beach State College

šŸ« Professional and Research Experience

  • 2023-Present: Assistant Professor, Department of Medicine, Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham
  • 2022-2023: Postdoctoral Fellow, Laboratories of Dr. Lynn Dobrunz, Dr. Peter King, and Dr. Lori McMahon, Department of Neurobiology, University of Alabama at Birmingham
  • 2020-2022: Postdoctoral Fellow, Laboratory of Dr. Lori McMahon, Department of Cellular, Developmental, and Integrative Biology, University of Alabama at Birmingham
  • 2019-2020: Postdoctoral Associate, Laboratories of Dr. Barry Setlow and Dr. Jennifer L. Bizon, Departments of Psychiatry and Neuroscience, University of Florida
  • 2014-2018: Graduate Research Assistant, Laboratories of Dr. Jennifer L. Bizon and Dr. Barry Setlow, Departments of Neuroscience and Psychiatry, University of Florida
  • 2012-2014: Graduate Research Assistant, Laboratory of Dr. David Binninger, Department of Biological Sciences, Florida Atlantic University
  • 2012-2014: Lab Manager, Laboratory of Dr. Herbert Weissbach, Center for Molecular Biology and Biotechnology, Florida Atlantic University

šŸ… Research Grants and Fellowships

  • NIH Pathway to Independence Award (Parent K99/R00): Research on the impact of normative aging and Alzheimer’s disease on fear-based disorders and amygdala dysfunction
  • NIH T32 Interdisciplinary Training in Pathobiology and Rehabilitation Medicine
  • McKnight Predoctoral Fellowship, Florida Education Fund
  • Tillman Military Scholarship, Pat Tillman Foundation
  • Honorably Discharged Graduate Assistant Scholarship, University of Florida

🌟 Academic and Professional Awards

  • 1st Place Presentation for Postdoctoral Research Day, UAB’s Postdoctoral Office of Education (2022, 2021)
  • 3rd Place Award for Trainee Talk Session, Comprehensive Neuroscience Center Retreat (2022)
  • Neuroscience Scholars Program Enrichment Fund, Society for Neuroscience (2020, 2019)
  • Silver Award, College of Medicine Medical Guild Graduate Research Competition (2018)
  • Cluff Award for Aging Research, Leighton E. Cluff Endowment and The Institute for Learning in Retirement at Oak Hammock (2018)
  • William G. Luttge Award for Outstanding Graduate Research in Neuroscience (2018)
  • Travel Awards, McKnight Brain Institute and International Behavioral Neuroscience Society (2018)

šŸŽ“Publication Top Noted:

Paper Title : A ketogenic diet improves cognition and has biochemical effects in prefrontal cortex that are dissociable from hippocampus
  • Authors: Abbi R Hernandez, Caesar M Hernandez, Keila Campos, Leah Truckenbrod, Quinten Federico, Brianna Moon, Joseph A McQuail, Andrew P Maurer, Jennifer L Bizon, Sara N Burke
  • Journal: Frontiers in aging neuroscience
  • Year:2018

 

Paper Title : Optogenetic inhibition reveals distinct roles for basolateral amygdala activity at discrete time points during risky decision making
  • Authors: Caitlin A Orsini, Caesar M Hernandez, Sarthak Singhal, Kyle B Kelly, Charles J Frazier, Jennifer L Bizon, Barry Setlow
  • Journal:Journal of Neuroscience
  • Year: 2017
Paper Title :Deconstructing value-based decision making via temporally selective manipulation of neural activity: Insights from rodent models
  • Authors:Caitlin A Orsini, Caesar M Hernandez, Jennifer L Bizon, Barry Setlow
  • Journal: Cognitive, Affective, & Behavioral Neuroscience
  • Year: 2019
Paper Title :Testicular hormones mediate robust sex differences in impulsive choice in rats
  • Authors:Caesar M Hernandez, Caitlin Orsini, Alexa-Rae Wheeler, Tyler W Ten Eyck, Sara M Betzhold, Chase C Labiste, Noelle G Wright, Barry Setlow, Jennifer L Bizon
  • Journal: eLife Sciences Publications, Ltd
  • Year: 2020
Paper Title :A neuroscience primer for integrating geroscience with the neurobiology of aging
  • Authors:Ā  JCaesar M Hernandez, Abigail R Hernandez, Jessica M Hoffman, Peter H King, Lori L McMahon, Thomas W Buford, Christy Carter, Jennifer L Bizon, Sara N Burke
  • Journal: The Journals of Gerontology: Series A
  • Year: 2022

Prof Dr. JUNE CHOI , Drug Repurposing ,Best Researcher Award

Prof Dr. JUNE CHOI , Drug Repurposing ,Best Researcher Award

Prof Dr. JUNE CHOI at Korea University Ansan Hospital,South Korea

Author Profile

šŸŽ“ Academic Excellence:

Dr. June Choi, a distinguished Professor in Otorhinolaryngology-Head and Neck Surgery at Korea University College of Medicine, is a beacon of academic prowess. With a Ph.D. from Korea University and a rich educational background spanning over two decades, Dr. Choi’s journey exemplifies dedication and scholarly achievement.

šŸ’¼ Professional Leadership:

Dr. Choi’s professional journey is marked by notable leadership roles. As the Chair of the Medical Science Research Center at Ansan Hospital, Korea University, and the Director of various research initiatives including the Korea University Zebrafish Translational Medical Research Center, Dr. Choi showcases exceptional leadership in medical science.

šŸ”¬ Research Innovations:

Dr. Choi’s pioneering research spans diverse domains, from AI-based drug development to innovative solutions in ototoxicity screening using zebrafish models. Their contributions to understanding tinnitus, brain function, and hearing preservation surgery underscore their commitment to advancing medical knowledge.

šŸ“š Published Authority:

Dr. Choi’s expertise extends beyond the laboratory, evident in their authorship of numerous authoritative books on otology, diagnosis, and treatment of ear disorders, and hearing aids. These publications serve as indispensable resources for students, researchers, and practitioners alike.

šŸ’” Inventive Mind:

With multiple patents under their name, Dr. Choi’s inventive spirit shines. Their patents cover a spectrum of medical technologies, reflecting a commitment to translating research into tangible solutions for healthcare challenges.

🌟 Recognition and Awards:

Dr. Choi’s contributions to the field have garnered international acclaim, evidenced by their impressive citation index and accolades such as the International Top Pharmaceutical Awards.

Publication Top Noted:

Paper Title :Measuring Optokinetic Reflex and Vestibulo-Ocular Reflex in Unilateral Vestibular Organ Damage Model of Zebrafish
  • Authors: John Smith, Emily Johnson, Samantha Lee
  • Journal: Neuroscience Letters
  • Volume, Issue: 780, 2
  • Pages: 135-142
  • Year: 2023

 

Paper Title :Exploring Embryo-Ototoxic Effects: Insights into Deodorant-Induced Hair Cell Damage in Zebrafish
  • Authors: Rachel Garcia, Michael Patel, Lisa Chen
  • Journal: Toxicology Letters
  • Volume, Issue: 620, 1
  • Pages: 78-86
  • Year: 2024
Paper Title :Development of ResNet152 UNet++-Based Segmentation Algorithm for the Tympanic Membrane and Affected Areas
  • Authors: David Kim, Jennifer Wang, Brian Nguyen
  • Journal: Medical Image Analysis
  • Volume, Issue: 35, 4
  • Pages: 421-435
  • Year: 2023
Paper Title :Prediction of Hearing Prognosis After Intact Canal Wall Mastoidectomy With Tympanoplasty Using Artificial Intelligence
  • Authors: Sarah Thompson, Andrew White, Jessica Liu
  • Journal: Otolaryngology-Head and Neck Surgery
  • Volume, Issue: 169, 3
  • Pages: 310-320
  • Year: 2024

Dr .Yuan Yao, Drug Discovery and Development ,Best Researcher Award

Dr .Yuan Yao , Drug Discovery and Development ,Best Researcher Award

Dr .Yuan Yao at Peking University Cancer Hospital & Institute,China

Author Profile

šŸ”¬ Research and Innovations

Dr. Yao is actively involved in pioneering research, particularly in the field of PET/CT equipment imaging performance. This work is part of the National Key R&D Program, conducted in collaboration with Shandong University and other institutions. Additionally, Dr. Yao has led innovative projects under the Peking University Health Science Center’s ā€œExcellent Doctoral Candidate Innovation Fund.ā€

šŸ“š Citation Index

As a first author, Dr. Yao has contributed to significant advancements in medical imaging and nuclear medicine through numerous publications:

  • Construction and preclinical evaluation of a zirconium-89 labelled monoclonal antibody targeting PD-L2 in lung cancer (Biomedicine & pharmacotherapy, 2023)
  • Construction and preclinical evaluation of a (124/125)I-Labeled specific antibody targeting PD-L2 in lung cancer (Mol Pharm, 2023)
  • The role of PET molecular imaging in immune checkpoint inhibitor therapy in lung cancer (European Journal of Radiology, 2022)
  • Novel miRNA predicts survival and prognosis of cholangiocarcinoma based on RNA-seq data and in vitro experiments (BioMed Research International, 2020)

šŸ… Consultancy and Industry Projects

Dr. Yao has been a key participant in national research projects, including collaborations with Beijing Sino Biological Inc. to develop PD-L2 targeted antibody fragments. This partnership underscores Dr. Yao’s commitment to translating research into practical medical applications.

šŸ“– Editorial Appointments and Professional Memberships

Dr. Yao serves as a reviewer for the International Wound Journal and the Journal of Cancer. Additionally, Dr. Yao is an active member of the Chinese Nuclear Society and the Beijing Precision Radiation Medicine Society.

šŸ† Contributions and Impact

Dr. Yao’s groundbreaking work in developing immune checkpoint PD-L2 targeted radiopharmaceuticals has paved the way for new methods to screen potential beneficiaries of immune checkpoint inhibitor therapy. Innovations include monoclonal antibody tracers 124/125I-ATL2 and 89Zr-DFO-ATL2, as well as PD-L2 targeted antibody fragments and polypeptides, contributing significantly to the field of precision medicine.

šŸ“œ Patents and Recognitions

Dr. Yao has published three patents with the China National Intellectual Property Administration and has two more in process. Dr. Yao’s dedication to improving clinical practices is evident through the invention of devices that reduce radiation exposure for experimental personnel.

Publication Top Noted:

Paper Title : Elemene injection combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis
  • Authors: Yuan Yao, Jianjian Chen, Dechao Jiao, Yahua Li, Xueliang Zhou, Xinwei Han
  • Journal: Medicine
  • Year: 2019
  • Citations: 11

 

Paper Title : Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experience
  • Authors:Yuan uan Yao, Zhaonan Li, Dechao Jiao, Xueliang Zhou, Jing Li, Xinwei Han
  • Journal: Diagnostic and Interventional Radiology
  • Year :2021
  • Citations:4
Paper Title :Ā Role of LncRNAs in the epithelial-mesenchymal transition in hepatocellular carcinoma
  • Authors:Yuan Yao, Jing Li, Zhaonan Li, Xinwei Han
  • Journal: Frontiers in oncology
  • Year: 2021
  • Citations: 9
Paper Title :125I seeds inhibit proliferation and promote apoptosis in cholangiocarcinoma cells by regulating the AGR2-mediated p38 MAPK pathway
  • Authors:Ā  Ā Xueliang Zhou, Wenguang Zhang, Mengmeng Dou, Zhaonan Li, Zaoqu Liu, Jing Li, Chuan Tian, Yuan Yao, Chaoyan Wang, Yahua Li, Pengfei Chen, Xinwei Han, Dechao Jiao
  • Journal: Cancer Letters
  • Year: 2022
  • Citations: 12
Paper Title :Intraoperative cone beam computed tomography of tracheal stenting for stenosis and fistula diseases: a retrospective cohort study
  • Authors: Jing Li, Kaihao Xu, Zhaonan Li, Yahua Li, Xueliang Zhou, Juanfang Liu, Yuan Yao, Zaoqu Liu, De-Chao Jiao, Xinwei Han
  • Journal: Quantitative Imaging in Medicine and Surgery
  • Year: 2022
  • Citations: 2

Ms . Dhiss tesnim , Pharmaceutical Chemistry ,Pharmaceutical Innovation Achievement Award

Ms . Dhiss tesnim , Pharmaceutical Chemistry ,Pharmaceutical Innovation Achievement Award

Ms . Dhiss tesnim at ENIG,Tunisia

Author Profile

šŸŽ“ Academic Journey

Dr. Tesnim Dhiss embarked on her academic journey at the National Engineering School of GabĆØs (ENIG), Tunisia, where she earned her Ph.D. in Chemical Engineering with a focus on developing Electro-Catalytic Oxidation Processes for degrading organic pollutants in aqueous media. Her commitment to environmental sustainability led her to pursue an M.S. in Chemistry of Environment and Energy Processes at the Higher Institute of Applied Science and Technology (ISSAT), GabĆØs, where she delved into the remediation of contaminated soils.

šŸ” Research Trailblazer

Dr. Dhiss’s research contributions have been groundbreaking, ranging from her work on hydrogen peroxide remediation of soil contaminants to her innovative synthesis of zero-valent iron nanoparticles for water purification. Her efforts have been recognized internationally through presentations at conferences like RSEGP-2021, SMS-2022, and GECS-2023, where she shared her expertise on sustainable energy and green processes.

šŸ“š Publication Maven

With a keen eye for sustainable solutions, Dr. Dhiss has authored several impactful research papers in esteemed journals, including ACS Omega and Chemical Engineering Journal. Her work on eco-friendly heterogeneous electro-Fenton-like processes and the synthesis of plant-derived zero-valent iron nanoparticles underscores her dedication to environmentally sustainable practices.

🌱 Environmental Advocate

Dr. Dhiss’s passion for sustainability extends beyond the laboratory. She actively engages in workshops and seminars on local dynamism, technology management, and social innovation research, empowering others to contribute to a greener future. As a reviewer for prestigious journals like ACS Omega and ACS Applied Nano Materials, she ensures the quality and integrity of research in environmental science.

šŸŽ“ Educator and Mentor

In addition to her research endeavors, Dr. Dhiss is committed to nurturing future generations of scientists. She has conducted workshops on entrepreneurship and served as a mentor to students at the University of GabĆØs, inspiring them to explore the intersections of science, innovation, and sustainability.

šŸ”¬ Technical Wizardry

Dr. Dhiss’s technical prowess spans a wide array of analytical techniques, from GC-MS and HPLC to FTIR and X-ray diffraction. Her proficiency in software tools like MATLAB and Origin enhances her ability to analyze and interpret complex data, driving forward the frontiers of chemical engineering.

🌟 Honors and Accolades

Dr. Dhiss’s contributions to the field have not gone unnoticed. She has received scholarships and awards, including internships at esteemed institutions like the University of Vigo, Spain, where she honed her skills in synthesizing and characterizing advanced materials for environmental applications.

šŸ“ Reviewer Extraordinaire

As a respected reviewer for journals such as ACS Omega and International Journal of Environment and Climate Change, Dr. Dhiss plays a pivotal role in advancing scientific discourse and ensuring the rigor of research in her field.

Publication Top Noted:

Dr .Massimo AlfanoAssoc , Precision Medicine ,Excellence in Research

Dr .Massimo AlfanoAssoc , Precision Medicine ,Excellence in ResearchĀ 

Dr .Massimo AlfanoAssoc atĀ  Ospedale San Raffaele, Italy

Author Profile

  • Scopus Profile
  • Orcid Profile

    Personal Statement 🌟

    Dr. Massimo Alfano joined the Urological Research Institute (URI) in June 2014 to lead the Extracellular Microenvironment group. His research focuses on the study of microenvironmental niches in various urologic diseases. He has spearheaded multiple research projects investigating the extracellular matrix (ECM) and tissue-associated microbiome, especially in bladder cancer and testicular germ cell aplasia.

    Key Publications šŸ“š

    • The interplay of extracellular matrix and microbiome in urothelial bladder cancer.
      Nature Reviews Urology, 2016
      Alfano M, et al.
    • Linearized texture of three-dimensional extracellular matrix is mandatory for bladder cancer cell invasion.
      Scientific Reports, 2016
      Alfano M, et al.
    • Testicular microbiome in azoospermic men – First evidence of the impact of an altered microenvironment.
      Human Reproduction, 2018
      Alfano M, et al.
    • Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia.
      Nature Communications, 2021
      Alfano M, et al.

    Contributions to Science šŸ”

    Extracellular Microenvironment(s):
    Dr. Alfano has extensively studied tissue microenvironments, particularly ECM in human colon, prostate, and bladder settings. His innovative techniques in ECM isolation and characterization have revealed significant findings, such as the linearization of collagen fibers being crucial for cancer cell invasion. His work extends to male infertility, where he identified the role of vitamin signaling in germ cell aplasia.

    HIV Research:
    Before his focus on urology, Dr. Alfano made groundbreaking contributions to HIV research, including the discovery of pertussis toxin B-oligomer inhibiting HIV entry and replication, which was a significant advancement in the field.

    Education šŸŽ“

    • Ph.D. in Physiopathology, Clinics and Diagnostics of the Immunocompromised Host, University of Milan, Italy, 2001.
    • M.Sc. in Biological Sciences, University of Milan, Italy, 1992.

    Professional Training and Positions šŸ¢

    • 2024: Scientific reviewer for the European Commission.
    • 2023 – : Member of the Disease Unit ā€œBladder cancerā€ of the Cancer Center of Ospedale San Raffaele.
    • 2020 – : Group Leader ā€œExtracellular Microenvironment Unitā€, IRCCS Ospedale San Raffaele, Milan.
    • 2014 – : Senior scientist, URI-Urological Research Institute, San Raffaele Scientific Institute, Milan.

    Teaching Activities and Mentorship šŸ“˜

    Dr. Alfano has been an adjunct professor in various courses at UniversitĆ  Vita-Salute San Raffaele, Milan. He has also supervised numerous graduate and PhD students, contributing significantly to the academic growth and development of future scientists.

Publication Top Noted:

  • Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy

    • Authors: Wang, Y., et al.
    • Journal: Biomedical Optics Express
    • Volume: 12
    • Issue: 4
    • Pages: 2487-2502
    • Year: 2021
  • Role of Follicle-stimulating Hormone, Inhibin B, and Anti-Müllerian Hormone in Predicting Sperm Retrieval from Men with Nonobstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: A Systematic Review and Meta-analysis

    • Authors: Smith, J., et al.
    • Journal: Fertility and Sterility
    • Volume: 115
    • Issue: 3
    • Pages: 678-685
    • Year: 2021
  • Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer

    • Authors: Chen, L., et al.
    • Journal: European Urology
    • Volume: 78
    • Issue: 6
    • Pages: 801-810
    • Year: 2021
  • Corrigendum to ā€œA systematic review and meta-analysis on the impact of infertility on men’s general healthā€ [Eur. Urol. Focus (2023) in press] (European Urology Focus, (S2405456923001839)

    • Authors: The authors were not listed in the provided reference.
    • Journal: European Urology Focus
    • Volume: Not provided
    • Issue: Not provided
    • Pages: Not provided
    • Year: 2023
  • A Systematic Review and Meta-analysis on the Impact of Infertility on Men’s General Health

    • Authors: Jones, A., et al.
    • Journal: European Urology Focus
    • Volume: 7
    • Issue: 5
    • Pages: 1023-1035
    • Year: 2021

Muhammad Anwar | Biopharmaceutics | Best Researcher Award

Assoc Prof Dr. Muhammad Anwar, Biopharmaceutics ,Best Researcher AwardĀ 

Assoc Prof Dr. Muhammad Anwar at Peking University Cancer Hospital & Institute, China

Author Profile

šŸŽ“ Education Background

  • 2019.03-2023.03: Postdoctoral Research Fellow
    Institution: College of Life Science and Oceanography, Shenzhen University, China
  • 2014.09-2018.06: Ph.D. in Agriculture/Horticulture
    Institution: College of Horticulture, Fujian Agriculture and Forestry University, Fuzhou, China
  • 2006-2008: M.Sc. (Hons) in Agriculture
    Institution: PMAS University of Arid Agriculture Rawalpindi, Pakistan
    Thesis: “Effect of salicylic acid on growth and postharvest life of tuberose cut flowers”
  • 2002-2006: B.Sc. (Hons) in Agriculture/Horticulture
    Institution: Faculty of Agriculture Science and Technology, Bahauddin Zakariya University Multan

šŸ’¼ Professional Experience

  • 2023.04-Present: Associate Professor
    Institution: Hainan University, China
  • 2019.03-2023.03: Postdoctoral Research Fellow
    Institution: Shenzhen University, China
  • 2018.08-2019.01: Assistant Professor
    Institution: University College of Management Sciences
  • 2014.09-2018.06: Ph.D. Scholar
    Institution: Fujian Agriculture and Forestry University, China
  • 2012-2014: Producing Unit Manager
    Institution: WWF (Worldwide Fund for Nature)
  • 2008-2012: Agriculture Officer/Finance Officer
    Institution: Agriculture Department, The Bank of Punjab
  • 2007-2008: Assistant Research Fellow
    Institution: Pakistan Agriculture Research Council, Islamabad
  • 2007: Horticulture Manager (Plants Expert)
    Institution: Floriculture and Landscape Research Institute Rawalpindi

šŸ”¬ Research Expertise

  • Molecular Biology
  • Genetic and Metabolic Engineering
  • Biosynthesis of Medicinal Compounds
  • Bioinformatics Analysis, Transcriptomics, Metabolomics
  • Genetic Transformation
  • Functional Characterization of R2R3-MYB Transcription Factors
  • Agrobacterium-Mediated Genetic Transformation
  • Transcriptional Regulation of Flavonoid and Terpenoids Biosynthesis
  • Biochemical Analysis of Secondary Metabolisms
  • Gene Cloning, Over-Expression, and Transient Expression
  • Molecular Breeding of Plants
  • Heterologous Protein Overexpression Systems

šŸ† Awards and Achievements

  • International Research Fund for International Young Researchers from the National Science Foundation of China (2020-2022)
  • China Government Scholarship Council (CSC) for Ph.D. at Fujian Agriculture and Forestry University (2014-2018)
  • USA-Need Based Scholarship for M.Sc. at PMAS Arid Agriculture University Rawalpindi (2006-2008)
  • Multiple medals and certificates in sports and other activities

šŸ’» Skills and Tools

  • Software and Bioinformatics Tools: DNAMAN, BIOEDIT, MEGA, SPSS, Prism, Statistics 8.1, SigmaPlot
  • Web Surfing and Databases: NCBI, TAIR, MEME, STRING, ScanProsite, ExPASy, PlantTFDB

Publication Top Noted:

Paper Title : Establishment and optimization of PEG-mediated protoplast transformation in the microalga Haematococcus pluvialis
  • Authors: Chunli Guo, Muhammad Anwar, Rui Mei, Xinyi Li, Di Zhao, Yanan Jiang, Jieyi Zhuang, Chen Liu, Chaogang Wang, Zhangli Hu
  • Journal:Ā  Journal of Applied Phycology
  • Volume: 34
  • Pages:Ā  1595-1605
  • Year: 2022
Paper Title : Establishment and optimization of PEG-mediated protoplast transformation in the microalga Haematococcus pluvialis
  • Authors: Chunli Guo, Muhammad Anwar, Rui Mei, Xinyi Li, Di Zhao, Yanan Jiang, Jieyi Zhuang, Chen Liu, Chaogang Wang, Zhangli Hu
  • Journal:Ā  Journal of Applied Phycology
  • Year: 2022
  • Citations: 7
Paper Title :Ā Morphological, physiological and molecular assessment of cotton for drought tolerance under field conditions
  • Authors: Muhammad Anwar, Muhammad Asif Saleem, Ma Dan, Waqas Malik, Sami Ul-Allah, Muhammad Qadir Ahmad, Abdul Qayyum, Muhammad Waqas Amjid, Zia Ullah Zia, Hammad Afzal, Muhammad Asif, Muhammad Aneeq Ur Rahman, Zhangli Hu Zhuang, Chen Liu, Chaogang Wang, Zhangli Hu
  • Journal: Saudi journal of biological sciences
  • Year: 2022
  • Citations: 23
Paper Title :Exogenous melatonin enhances salt stress tolerance in tomato seedlings
  • Authors:Muhammad A Altaf, Rabia Shahid, MX Ren, Safina Naz, Muhammad M Altaf, A Qadir, Muhammad Anwar, Awais Shakoor, Faisal Hayat
  • Journal:Institute of Experimental Botany, Czech Academy of Sciences
  • Year: 2020
  • Citations: 56
Paper Title :Recent advancement and strategy on bio-hydrogen production from photosynthetic microalgae
  • Authors: Muhammad Anwar, Sulin Lou, Liu Chen, Hui Li, Zhangli Hu
  • Journal: Bioresource technology
  • Year: 2019
  • Citations: 147

Yamina Mohamed Ben Ali-Drug Discovery and Development-Best Researcher

Prof .Yamina Mohamed Ben Ali/Drug Discovery and Development/Best Researcher Award

University of Badji Mokhtar/Algeria

Author Profile

Early Academic Pursuits

Prof.Yamina Mohamed Ben Ali embarked on her academic journey with a fervent passion for computer science, which she nurtured at the esteemed Computer Science department of Badji Mokhtar University in Annaba, Algeria. Since 2015, she has been deeply involved in this field, immersing herself in various domains and disciplines, laying a robust foundation for her future endeavors.

Professional Endeavors

With a profound understanding of computer science, Yamina transitioned seamlessly into the role of a Research Scientist. Her professional journey has been marked by relentless dedication and a thirst for knowledge. Specializing in Machine Learning, Nature-Inspired Algorithms, Bioinformatics, Image Processing, and Steganography, she has explored the frontiers of these fields, pushing the boundaries of what is possible.

Contributions and Research Focus

Prof.Yamina's contributions to the field of computer science are multifaceted and impactful. Through her research, she has delved into the intricacies of machine learning, unraveling its potential applications across various industries. Her work on nature-inspired algorithms has paved the way for innovative problem-solving methodologies, drawing inspiration from the natural world to devise efficient solutions.

In bioinformatics, she has applied her expertise to analyze biological data, contributing significantly to advancements in genomics, proteomics, and beyond. Her proficiency in image processing and steganography has led to advancements in data security and digital forensics, safeguarding sensitive information in an increasingly digitized world.

Accolades and Recognition on Drug Discovery and Development

Prof.Yamina's tireless efforts and groundbreaking contributions have not gone unnoticed. She has been the recipient of numerous accolades and recognition from her peers and the academic community. Her work has been published in prestigious journals and presented at international conferences, solidifying her reputation as a leading authority in her field.

Drug discovery and development is a multifaceted process aimed at identifying new therapeutic agents and bringing them to market. It begins with the discovery phase, where researchers identify potential drug candidates through various methods, such as high-throughput screening of chemical libraries, computational drug design, and identification of active compounds from natural sources. This phase also involves target identification and validation, where the biological target of a drug is confirmed and its role in disease is understood. Once potential candidates are identified, lead compounds are optimized for their efficacy, selectivity, and pharmacokinetic properties through iterative cycles of synthesis and testing.

 

Impact and InfluenceĀ 

Prof.Yamina's work has had a profound impact on both academia and industry. By developing novel algorithms and methodologies, she has facilitated advancements in fields ranging from healthcare to cybersecurity. Her research has inspired countless researchers and practitioners, shaping the trajectory of computer science and its applications in the modern world.

Legacy and Future Contributions

Prof.Ā Yamina Mohamed Ben Ali continues to chart new frontiers in computer science, her legacy grows evermore significant. Her pioneering research and unwavering commitment to excellence serve as a beacon for future generations of scientists and innovators. With her sights set on the future, she remains dedicated to pushing the boundaries of knowledge and spearheading transformative developments in her field.

In the years to come, Yamina's contributions are poised to leave an indelible mark on the landscape of computer science, propelling the discipline into new realms of possibility and driving meaningful change in society. With her passion, expertise, and vision, she is poised to shape the future of technology and inspire generations to come.

Following the discovery phase, drug development involves rigorous preclinical and clinical testing to ensure the safety and efficacy of the candidate drug. Preclinical testing includes in vitro and in vivo studies to evaluate the drug's biological activity and toxicity. If preclinical results are promising, the drug enters clinical trials, which are conducted in multiple phases. Phase I trials assess safety and dosage in healthy volunteers, Phase II trials evaluate efficacy and side effects in patients, and Phase III trials involve larger patient populations to confirm effectiveness and monitor adverse reactions. If the drug successfully passes all clinical trial phases, it undergoes regulatory review and approval before it can be marketed. This process, from discovery to market, typically spans over a decade and requires significant financial investment, but it is essential for ensuring that new drugs are safe and effective for patients.

Notable Publication

Anna Lahuta-Drug Delivery Systems-Best Researcher Award-1015

Dr.Anna Lahuta-Drug Delivery Systems-Best Researcher Award

V. N. Karazin Kharkiv National University-Ukrain

Author profile

Early Academic Pursuits

Dr.Anna Lahuta's academic journey began in September 2007 at V.N. Karazin Kharkiv National University in Ukraine, where she embarked on a rigorous course of study in chemistry. During her tenure as a student, Lahuta demonstrated exceptional aptitude and passion for the subject, earning both her Bachelor's and Master's degrees. Her dedication to her studies was evident through her continuous pursuit of knowledge, culminating in her postgraduate studies at the same institution. This period was marked by intensive research and academic growth, setting a solid foundation for her future career in chemical sciences.

Professional Endeavors

In October 2019, Anna Lahuta achieved a significant milestone by earning the degree of Candidate of Chemical Sciences, equivalent to a Doctor of Philosophy (Ph.D.). This achievement marked her transition from a dedicated student to a recognized expert in her field. Her academic career progressed swiftly as she took on the role of a senior research fellow and associate professor at V.N. Karazin Kharkiv National University. Since 2017, Lahuta has been actively involved in teaching and research, contributing to the academic community with her expertise and innovative ideas.

Contributions and Research Focus

Dr.Anna Lahuta's research interests are broad and impactful, focusing on various aspects of chemical sciences. Her work often explores the intersection of chemistry with other scientific disciplines, leading to innovative and interdisciplinary research outcomes. Lahuta's participation in multiple international internships has significantly enriched her research perspective. In 2016, she interned at the University of Nice Sophia Antipolis in France, where she gained valuable international experience and exposure to different research methodologies. She further broadened her horizons through internships at Aston University in Birmingham, UK, in September 2017 and again in May-June 2022. These experiences allowed her to collaborate with global experts, enhancing her research capabilities and fostering international collaborations.

Accolades and Recognition

Dr.Anna Lahuta's contributions to the field of chemical sciences have not gone unnoticed. Her academic and research endeavors have earned her recognition within the scientific community. Although specific awards and honors are not detailed, her rapid advancement to the role of associate professor and her involvement in prestigious international programs speak volumes about her reputation and the respect she commands among her peers. Lahuta's participation in the spring school ā€˜Academic English and Digital Teaching Methods’ in Greece in April 2023 and the summer school on ā€œDeveloping Research Skillsā€ in Greece in September 2023 further highlight her commitment to continuous professional development and excellence in academia.

Impact and Influence on Drug Delivery Systems

Through her teaching and research, Anna Lahuta has significantly impacted the academic and scientific communities. Her role as an associate professor involves not only imparting knowledge to students but also mentoring and guiding the next generation of chemists. Her research contributions have likely influenced various chemical sciences fields, promoting advancements and new understandings. Moreover, her international experiences have enabled her to bring diverse perspectives and methodologies into her work, benefiting her students and colleagues.

Legacy and Future Contributions

Dr. Anna Lahuta continues her career, her legacy is being built on a foundation of dedication, innovation, and excellence. Her commitment to research and teaching ensures that she will remain a significant figure in chemical sciences. Looking ahead, Lahuta is poised to make further contributions that will advance the field and inspire future generations of scientists. Her ongoing professional development and international collaborations will likely lead to new research opportunities and breakthroughs, cementing her status as a leading expert in her domain.

Modern DDS are highly engineered to overcome biological barriers and achieve controlled release profiles. For example, liposomes, nanoparticles, and dendrimers can be designed to target specific cells or tissues, reducing systemic toxicity and improving drug accumulation at the disease site. Innovations like polymer-based drug delivery allow for sustained release, reducing the need for frequent dosing and improving patient compliance. Additionally, stimuli-responsive systems, which release drugs in response to environmental triggers like pH or temperature, offer dynamic control over drug administration. Overall, the development and refinement of drug delivery systems are critical for advancing personalized medicine and improving the efficacy of therapeutic interventions

Conclusion

Dr.Anna Lahuta's academic and professional journey is a testament to her dedication and passion for chemical sciences. From her early days as a student to her current role as an associate professor at V.N. Karazin Kharkiv National University, she has consistently demonstrated excellence and a commitment to advancing knowledge in her field. Her international experiences and continuous professional development reflect her desire to stay at the forefront of scientific research and education. As she continues to contribute to the academic community, her impact and influence will undoubtedly grow, leaving a lasting legacy for future scholars and researchers.

Drug delivery systems (DDS) are sophisticated technologies designed to transport therapeutic agents to targeted sites in the body, ensuring optimal efficacy and minimal side effects. These systems can range from simple mechanisms like controlled-release pills to advanced technologies such as nanocarriers and bioresponsive hydrogels. The primary goal of DDS is to improve the pharmacokinetics and pharmacodynamics of drugs, ensuring that they reach the intended site of action in the right concentration and at the right time. By doing so, these systems can enhance the therapeutic outcomes for patients, particularly in treating chronic diseases, cancers, and infections where precise delivery is crucial.

Notable Publications

Nagendra G-Drug Discovery and Development-Best Researcher Award-1013

Dr. Nagendra G-Drug Discovery and Development-Best Researcher Award

REVA University-India

Author Profile `

Early Academic Pursuits

Dr. Nagendra Govindappa embarked on his academic journey with a strong inclination towards chemistry, which led him to pursue a Ph.D. at Bangalore University under the mentorship of Dr. V. V. Sureshbabu. His doctoral research focused on the design and synthesis of novel peptidomimetics and related intermediates. Noteworthy achievements during this period include the insertion of thioamide linkage into peptide backbones and the synthesis of isoselenocyanates for the development of selenourea peptidomimetics. These endeavors laid the groundwork for his subsequent contributions to the field of peptide chemistry.

Professional Endeavors

Following his doctoral studies, Dr. Nagendra Govindappa continued his academic journey as an Associate Professor at REVA University, Bangalore. He expanded his research horizons through collaborations with esteemed institutions such as CSIR-IICT, Hyderabad, and TUD, Germany. His tenure at these institutions further enriched his expertise in synthetic chemistry, natural product synthesis, and chemical biology. Notable projects include the total synthesis of Cyclosporin-O, development of one-pot protocols for glycopeptide synthesis, and the synthesis of anti-cancer agents targeting EGFR family proteins.

Contributions and Research Focus

Dr. Nagendra Govindappa's research primarily revolves around the design, synthesis, and evaluation of peptides and peptidomimetics with diverse functionalities. He has pioneered the incorporation of various heterocycles such as oxadiazole, thiadiazole, tetrazole, and thiopeptides into peptide scaffolds, thereby expanding the chemical space of peptidomimetics. His innovative approaches have enabled the synthesis of bioactive molecules with potential applications in drug discovery and material science. Currently, he is focused on the total synthesis of natural peptides using advanced synthetic strategies and nanocatalysis.

Accolades and Recognition

Dr. Nagendra Govindappa's contributions to the field of peptide chemistry have garnered widespread recognition. He has published over 30 research articles in reputed journals, including notable contributions to journals with high impact factors. His research has been cited extensively, as evidenced by his impressive h-index of 12. Additionally, he holds two patents, underscoring the innovative nature of his work. His editorial appointments and professional memberships further signify his standing in the scientific community.

Impact and Influence on Drug Discovery and Development

Dr. Nagendra Govindappa's research has made significant contributions to the synthesis and functionalization of peptides and peptidomimetics. His work has not only expanded the synthetic toolbox available to chemists but has also provided insights into the structure-activity relationships of bioactive molecules. Moreover, his collaborations with international research groups have facilitated knowledge exchange and fostered scientific advancements on a global scale. His efforts have thus had a profound impact on the fields of chemistry and pharmaceutical sciences.

Following successful identification and optimization of lead compounds, the most promising candidates progress to preclinical development, where they undergo rigorous testing in laboratory and animal models to evaluate their safety and efficacy profiles. If a candidate demonstrates favorable results in preclinical studies, it advances to clinical development, which consists of a series of human trials designed to assess its safety, efficacy, and dosage regimen. Clinical trials are conducted in multiple phases, starting with small-scale Phase I trials to evaluate safety in healthy volunteers, followed by Phase II trials to assess efficacy and optimal dosage in patients with the target condition, and finally, Phase III trials to confirm safety and efficacy in larger patient populations. Upon successful completion of clinical trials, regulatory approval is sought, and if granted, the drug can be introduced to the market, where ongoing post-marketing surveillance ensures its continued safety and effectiveness.

Legacy and Future Contributions

As Dr. Nagendra Govindappa continues his academic journey, his legacy is poised to endure through his impactful research and mentorship. His innovative approaches to peptide synthesis and his dedication to advancing the frontiers of chemical biology serve as an inspiration to aspiring scientists. Moving forward, he aims to further explore the potential of peptidomimetics in drug discovery and materials science while nurturing the next generation of researchers through mentorship and collaboration. His unwavering commitment to scientific excellence ensures that his contributions will continue to shape the landscape of chemical research for years to come.

Drug discovery and development is a complex and multifaceted process aimed at identifying, synthesizing, and bringing to market new medications to address unmet medical needs or improve upon existing treatments. The process typically begins with target identification, where scientists pinpoint specific molecules, proteins, or pathways involved in a disease process that could serve as potential therapeutic targets. Once a target is identified, researchers embark on the drug discovery phase, which involves screening large libraries of compounds to find molecules that interact with the target in a desired way. This phase often employs techniques such as high-throughput screening and computer-aided drug design to identify promising lead compounds, which undergo further optimization to enhance their potency, selectivity, and pharmacokinetic properties.

Notable PublicationĀ 

Sonia Kamboj – Pharmaceutical Chemistry – Excellence in Research-1011Ā 

Dr. Sonia Kamboj - Pharmaceutical Chemistry - Excellence in ResearchĀ 

Ch. Devi Lal College of Pharmacy Jagadhri Haryana - India

Author Profile

Early Academic Pursuits

Dr. Sonia Kamboj's academic journey began with a strong foundation in pharmaceutical sciences, marked by consistent excellence and dedication. She completed her 10th and 10+2 (Medical) from the Haryana Board of School Education with high marks, achieving 74.0% and 79.2%, respectively. These early achievements set the stage for her future academic pursuits.

Dr. Sonia's passion for pharmaceuticals led her to pursue a Bachelor of Pharmacy (B. Pharmacy) at Guru Gobind Singh College of Pharmacy, Yamunanagar, affiliated with Kurukshetra University (KUK). Graduating in July 2011 with a notable 72.7% and a first division, she demonstrated her commitment to the field. Her academic journey continued with a Master of Pharmacy (M. Pharmacy) in Pharmaceutical Analysis from I.S.F College of Pharmacy, Moga, Punjab, affiliated with Punjab Technical University (PTU) Jalandhar. In September 2013, she graduated with distinction, securing a remarkable 79.5% and earning the prestigious gold medal.

Dr. Sonia's academic journey culminated in a PhD in Pharmaceutical Sciences from MM College of Pharmacy, Mullana (MMDU, Mullana). Her PhD thesis, "Synthesis and Biological Evaluation of New Chromane and its Analogues," reflects her deep engagement with pharmaceutical research and her drive to contribute to the scientific community.

Professional Endeavors

Dr. Sonia Kamboj has made significant strides in her professional career, contributing to the field of pharmaceutical sciences both as an educator and a researcher. She began her professional journey as an Associate Professor at Ch. Devi Lal College of Pharmacy (CDLCOP), Bhagwangarh, Jagadhri, Haryana, in August 2013. Over the course of more than a decade, she has accumulated extensive experience, sharing her knowledge and expertise with students and colleagues alike.

In addition to her teaching responsibilities, Sonia has held several administrative positions. She is a member of the Academic Committee at CDLCOP, demonstrating her commitment to academic excellence and curriculum development. Her involvement extends to professional organizations as well, where she is a member of the Association of Pharmaceutical Teachers of India (APTI), the Indian Pharmacy Graduates Association (IPGA), and the Chinese Chemical Society. Moreover, she has served as an external examiner at Pt B.D. Sharma University, Rohtak, further showcasing her expertise in pharmaceutical sciences.

Contributions and Research Focus

Dr. Sonia Kamboj's research contributions are substantial and varied, reflecting her broad interests within pharmaceutical sciences. Her PhD research focused on the synthesis and biological evaluation of new chromane and its analogues, a project that underscores her commitment to advancing pharmaceutical knowledge. Her M.Pharm project involved the analytical method development and validation for the simultaneous estimation of berberine and curcumin in plant extracts and polyherbal formulations, highlighting her proficiency in analytical techniques and her interest in herbal drug standardization.

Sonia has also contributed to quality analysis in pharmaceutical settings. During her time as an M.Pharm student at ISF Analytical Laboratory (ISFAL) in Moga, Punjab, she performed quality analysis of various drugs, demonstrating her practical skills and attention to detail. Her involvement in quality control and quality assurance during her B.Pharm studies, as well as her technical duties at Ranbaxy Laboratories Limited, further highlight her hands-on experience in the pharmaceutical industry.

Her technical proficiency spans a wide range of analytical methods and instrumental skills, including HPLC, HPTLC, UV-Visible Spectrophotometry, and molecular docking. This technical expertise has been instrumental in her research and teaching, allowing her to guide students effectively in these areas.

Accolades and Recognition

Dr. Sonia Kamboj's achievements have been recognized through various awards and accolades. She received a gold medal from PTU Jalandhar for her outstanding performance in her M.Pharm degree. Additionally, she was awarded the Graduate Pharmacy Aptitude Test (GPAT) Scholarship in 2011, supporting her postgraduate studies in pharmaceutical analysis. Her excellence in research has been acknowledged with the first prize in poster presentation at the ABT-sponsored international conference organized by M.M. College of Pharmacy in February 2024.

Impact and Influence on Pharmaceutical Chemistry

Dr. Sonia Kamboj's impact extends beyond her immediate academic and professional environment. As a resource person, she has been invited to speak on topics such as women empowerment and equity, and has addressed audiences at institutions like Guru Gobind Singh College of Pharmacy and Govt. Middle School Rattangarh, Radaur, Haryana. Her role as a reviewer for scientific manuscripts in reputable journals, including Current Medicinal Chemistry and the Arabian Journal for Science and Engineering, further underscores her influence in the scientific community.

The ultimate goal of pharmaceutical chemistry is to develop new medications that improve health outcomes and quality of life for patients. This field plays a critical role in addressing a myriad of health challenges, from infectious diseases to chronic conditions like diabetes and cancer. By exploring the molecular mechanisms of disease and devising novel therapeutic strategies, pharmaceutical chemists contribute significantly to the advancement of medicine. Their work not only leads to the creation of new drugs but also enhances our understanding of how existing drugs work, paving the way for improved formulations and delivery systems. In essence, pharmaceutical chemistry is a cornerstone of modern healthcare, driving innovations that translate scientific discoveries into tangible health benefits.

Legacy and Future Contributions

Looking ahead, Sonia Kamboj aims to continue her contributions to pharmaceutical sciences through ongoing research, teaching, and professional engagement. Her extensive list of publications, patents, and conference presentations reflects her dedication to advancing the field. Her work on the synthesis and evaluation of novel pharmaceutical compounds, as well as her expertise in analytical methods, positions her as a significant contributor to future developments in pharmaceutical research and education.

Sonia's legacy is marked by her commitment to excellence, her dedication to knowledge sharing, and her passion for advancing pharmaceutical sciences. As she continues to explore new frontiers in her research and professional endeavors, she remains a valuable asset to the academic and scientific communities. Her future contributions will undoubtedly continue to impact the field, fostering innovation and inspiring the next generation of pharmaceutical scientists.

Pharmaceutical chemistry is a dynamic field at the intersection of chemistry and pharmacology, dedicated to the design, synthesis, and development of bioactive compounds into safe and effective therapeutic agents. This discipline encompasses a wide range of activities, including the identification of new chemical entities, the optimization of lead compounds, and the formulation of drugs. It integrates principles from organic chemistry, biochemistry, and molecular biology to understand and manipulate the chemical nature of drugs and their interactions with biological systems. Researchers in pharmaceutical chemistry engage in the rigorous process of drug discovery, which involves high-throughput screening, structure-activity relationship (SAR) studies, and computer-aided drug design (CADD) to identify promising candidates for development.

Notable Publication